Announce Date | 03/04/2025 |
EPS Normalized Actual | $2.58 (Beat by $0.17) |
EPS GAAP Actual | $2.58 (Beat by $0.17) |
Revenue Actual | $13.948B |
Revenue Surprise | Beat by $13948M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Feb 2030 | 12.56 | 4.93 | 12.31095 | 12.89512 | 1 |
Feb 2029 | 11.63 | 5.33 | 11.2544 | 12.0656 | 2 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Feb 2025) | 0.55 | 0.55 | 13.948B | -5% | 13948M |
FQ4 2024 (Nov 2024) | -2.49 | -2.49 | 9.445B | -3.29% | 9445M |
FQ3 2024 (Aug 2024) | 1.35 | 1.35 | 9.288B | -3.18% | 9288M |
FQ2 2024 (May 2024) | 1.14 | 1.14 | 8.847B | -7.01% | 8847M |
FQ1 2024 (Feb 2024) | 2.12 | 2.12 | 14.646B | -0.61% | 14646M |
FQ4 2023 (Oct 2023) | 1.21 | 1.21 | 9.756B | -8.52% | 9756M |
FQ3 2023 (Jul 2023) | 1.25 | 1.25 | 9.583B | 100% | 9583M |
FQ2 2023 (Apr 2023) | 1.12 | 1.12 | 9.467B | 100% | 9467M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2027 (Feb 2027) | 2.78871 | -- | 2.70799 | 2.85927 | 9 |
FQ4 2026 (Oct 2026) | 1.50506 | -- | 1.43356 | 1.54259 | 20 |
FQ3 2026 (Jul 2026) | 1.55425 | -- | 1.48042 | 1.593 | 10 |
FQ2 2026 (Apr 2026) | 1.22784 | -- | 1.16951 | 1.25846 | 13 |
FQ1 2026 (Feb 2026) | 2.66092 | 79.33 | 2.5839 | 2.72825 | 9 |
FQ4 2025 (Oct 2025) | 1.3123 | 289.74 | 1.24996 | 1.34502 | 11 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2027 (Feb 2027) | 9.5B | -- | 9.29B | 9.69B | 12 |
FQ4 2026 (Oct 2026) | 9.75B | -- | 9.39B | 9.93B | 21 |
FQ3 2026 (Jul 2026) | 9.51B | -- | 9.16B | 9.69B | 11 |
FQ2 2026 (Apr 2026) | 9B | -- | 8.68B | 9.18B | 14 |
FQ1 2026 (Feb 2026) | 13.89B | -0.45 | 13.58B | 14.16B | 7 |
FQ4 2025 (Oct 2025) | 9.52B | 0.82 | 9.17B | 9.71B | 10 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Feb 2025) | 0.55 | 0.55 | 100% | |
FQ4 2024 (Nov 2024) | -2.49 | -2.49 | 100% | |
FQ3 2024 (Aug 2024) | 1.35 | 1.35 | 100% | |
FQ2 2024 (May 2024) | 1.14 | 1.14 | 100% | |
FQ1 2024 (Feb 2024) | 2.12 | 2.12 | 100% | |
FQ4 2023 (Oct 2023) | 1.21 | 1.21 | 100% | |
FQ3 2023 (Jul 2023) | 1.25 | 1.25 | 100% | |
FQ2 2023 (Apr 2023) | 1.12 | 1.12 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Feb 2025) | $0B | $13.95B | $13948M | 100% |
FQ4 2024 (Nov 2024) | $0B | $9.45B | $9445M | 100% |
FQ3 2024 (Aug 2024) | $0B | $9.29B | $9288M | 100% |
FQ2 2024 (May 2024) | $0B | $8.85B | $8847M | 100% |
FQ1 2024 (Feb 2024) | $0B | $14.65B | $14646M | 100% |
FQ4 2023 (Oct 2023) | $0B | $9.76B | $9756M | 100% |
FQ3 2023 (Jul 2023) | $0B | $9.58B | $9583M | 100% |
FQ2 2023 (Apr 2023) | $0B | $9.47B | $9467M | 100% |